|
Market Closed -
Nasdaq Stockholm
12:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 1.928 SEK | -2.72% |
|
-4.55% | -2.13% |
| 10-20 | Irlab research behind linepemat published in journal | FW |
| 10-20 | IRLAB Therapeutics AB Announces Publication Of Preclinical Research Underpinning Linepemat In Peer-Reviewed Journal | CI |
Chart: Technical Analysis
Nasdaq StockholmSEK
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| IRLAB A | Delayed | |
Deutsche Boerse AG
| 6IRA | Delayed | |
|
OTC Markets
| IRLAF | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 2.075 | 2.075 | 2.32 |
| Spread/Res. | -7.08% | -7.08% | -16.90% |
| Spread/Supp. | +1.47% | +22.03% | +58.03% |
| Support | 1.9 | 1.58 | 1.22 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IRLAB A Stock
- Charts IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
